12:00 AM
 | 
Dec 23, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xiaflex regulatory update

Auxilium submitted an sBLA to FDA for Xiaflex to treat multiple Dupuytren's contracture concurrently. The injectable form of collagenase is approved in the U.S., Canada, Australia and the EU, where it is known as Xiapex, to treat Dupuytren's contracture in adult patients with a palpable cord, which affects joints in the hand. Earlier this month,...

Read the full 252 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >